https://www.globenewswire.com/news-release/2026/03/18/3258582/0/en/4DMT-Reports-Full-Year-2025-Financial-Results-Operational-Highlights-and-Expected-Upcoming-Milestones.html
4DMT Reports Full Year 2025 Financial Results, Operational
Completed enrollment in 4D-150 4FRONT-1 wet AMD Phase 3 trial within approximately 11 months, ahead of initial projections and reflecting strong interest...
full yearfinancial resultsreportsoperational